PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing
Clinical trial NCT04787302 · COMPLETED
Trial details
- NCT number
- NCT04787302
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2023-07-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.